Achievement of cardiometabolic goals among diabetic patients in Spain. A nationwide population-based study by Navarro-Vidal, Beatriz et al.
Achievement of Cardiometabolic Goals among Diabetic
Patients in Spain. A Nationwide Population-Based Study
Beatriz Navarro-Vidal, Jose´ R. Banegas, Luz M. Leo´n-Mun˜oz, Fernando Rodrı´guez-Artalejo,
Auxiliadora Graciani*
Department of Preventive Medicine and Public Health, Universidad Auto´noma de Madrid/IdiPAZ; CIBERESP, Madrid, Spain
Abstract
Background: No previous study has reported a comprehensive assessment of the attainment of cardiometabolic goals in
the diabetic population of a European country. We examined the achievement of cardiometabolic goals among diabetics in
Spain.
Methods and Findings: A cross-sectional survey was performed in 2008–2010 among 12,077 individuals representative of
the Spanish population aged $18 years. Information on cardiometabolic characteristics was collected at the participants’
homes through structured questionnaires, physical examination, and fasting blood samples. Attainment of cardiometabolic
goals was evaluated according to the most well-known guidelines. A total of 834 individuals had diabetes (fasting serum
glucose $126 mg/dl, or glycosylated hemoglobin $6.5%,) or were being treated with oral antidiabetic drugs or insulin).
Among diabetic patients, 661 (79.2%) were aware of their condition. Among the aware diabetic patients, only 11.4% had
neither general (body mass index,25 kg/m2) nor abdominal obesity (waist circumference#102 cm in men and#88 cm in
women), 8.6% consumed ,7% of calories daily from saturated fats, and 41.1% achieved the recommendation on weekly
physical activity. About 71% had glycosylated hemoglobin ,7%, 22% had blood pressure ,130/80 mmHg, and 36%
reached the LDL-cholesterol goal of ,100 mg/dl. Although a large proportion of aware diabetic individuals received
lifestyle medical advice, only 38% of overweight individuals and 20% of daily smokers were offered a specific strategy for
weight loss or quitting smoking, respectively.
Conclusions: In a European country with universal healthcare coverage, achievement of many cardiometabolic goals, in
particular lifestyle, among aware diabetic individuals is poor. This suggests a need for improvement in both clinical
guidelines’ implementation and patients’ adherence.
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Introduction
The control of cardiovascular risk factors, either through
lifestyle or drug treatment, have shown health benefits for diabetic
patients and those at high risk of diabetes [1]. Thus, American and
European clinical practice guidelines on diabetes management
have focused not only on glycemic control, but also on
modification of lifestyles and achievement of cardiovascular goals
in diabetic patients [2–4].
Most previous studies have focused on the control of a few
cardiovascular risk factors in persons with diabetes, generally,
serum glucose, blood pressure (BP), and lipids [5–9]. Moreover,
only some of these studies were population-based and represen-
tative of an entire country [5–7].
Thus, our objective was to examine the achievement of main
cardiometabolic goals among diabetic subjects in a representative
sample of the adult population of Spain. These goals include
lifestyles (not smoking, being physically active, having normal body
weight, reduced intake of dietary fat), biological variables (control
of blood glucose, blood pressure, LDL- cholesterol and albumin
excretion) and provision of health services (medical advice on
lifestyle, and treatment with angiotensin converting enzyme (ACE)
inhibitors, angiotensin II receptor blockers (ARB), statins or
aspirin, if indicated) [2–4]. To our knowledge, no published study
has reported a comprehensive assessment of the attainment of
cardiometabolic goals in the diabetic population of a European
country.
Methods
Ethics Statement
The study protocol was approved by the Clinical Research
Ethics Committee of the University Hospital La Paz in Madrid and
the Hospital Clı´nic in Barcelona. All the patients provided written
informed consent for the study.
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Research Design and Methods
The data were taken from the Study on Nutrition and
Cardiovascular Risk in Spain, whose methods have been reported
elsewhere [10]. In brief, this was a cross-sectional study conducted
from June 2008 through October 2010 on 12,948 individuals
representative of the non-institutionalized population of Spain
aged $18 years.
Study participants were selected by multistage clustered random
sampling. The sample was first stratified by province and by
municipality size. Clusters were then selected randomly in two
stages: municipalities and census sections. Finally, the households
within each section were selected by random telephone dialing
(landline telephone directory as sampling frame). Subjects in the
households were selected proportionally to Spanish population
distribution by sex and age. Information was collected by
telephone interview, and through face-to-face interview, physical
examination, and collection of blood and urine samples in the
households.
Diabetes was defined as 12-hour fasting serum glucose
$126 mg/dl or glycosylated hemoglobin (HbA1c) $6.5%, or
being treated with oral antidiabetic drugs or insulin [2]. Among
diabetic individuals, awareness of their condition was defined as a
positive response to the question: ‘‘Have you ever been told by the
doctor that you had diabetes or elevated blood sugar?’’ Glycemic
control was defined as glycosylated hemoglobin (HbA1c) ,7% [2].
Treatment was defined as reported current use of diabetes drug
therapy.
Study participants reported their smoking status. Physical
activity and habitual food consumption were based on question-
naires validated in the EPIC cohort of Spain [10–12]. The
nutrient intake was estimated using composition tables for Spanish
and foreign foods [10,13,14]. Individuals also reported physician-
diagnosed morbidity, in particular, ischemic heart disease, stroke
or heart failure, and the use of health care.
Weight, height, and waist circumference (WC) were measured
twice in each subject under standardized conditions [15], using
electronic scales (model Seca 841, precision to 0.1 kg), portable
extendable stadiometers (model Ka We 44 444Seca) and flexible,
inelastic belt-type tapes. Body mass index (BMI) was calculated as
weight in kg divided by squared height in m. BP was measured,
using standardized procedures [16], with validated automatic
devices (model Omron M6) and cuffs of three sizes according to
Table 1. Demographic and clinical characteristics among aware and unaware diabetic individuals.
Aware diabetes n = 661
Unaware diabetes
n = 173 p
Sex (%)
Women 41.7 42.2 0.920
Age (years) 64.4 62.2 0.151
Age (%)
18–44 7.2 16.2 0.004
45–64 37.0 30.3 0.149
$65 55.7 53.4 0.651
Education (%)
Less than high school 57.7 51.7 0.230
High school 24.9 31.9 0.110
University 17.4 16.3 0.771
Tobacco smoking in daily smokers
(No. of cigarettes per day) 15.6 19.5 0.138
Body mass index (kg/m2) 30.2 30.4 0.666
Waist circumference (cm)
Men 105.8 104.3 0.297
Women 99.1 98.5 0.733
Physical activitya (min/week) 139.2 154.7 0.432
Calorie intake from saturated fat (kcal) 234.4 248.6 0.302
Fasting glucose (mg/dl) 143.1 142.8 0.926
HbA1c (%) 6.5 6.0 ,0.001
Duration of diabetes (years) 7.7 –
Blood pressure (mmHg)
Systolic 142.6 140.1 0.227
Diastolic 77.4 78.8 0.218
LDL Cholesterol (mg/dl) 112.6 126.7 ,0.001
Urinary albumin:creatinine ratio (mg/g) 8.0 6.0 0.028
Data are presented as means for continuous variables and percentages for categorical variables, except for Urinary albumin:creatinine ratio presented as median.
aModerate or vigorous physical activity: $150 minutes/week of moderate intensity or $60 minutes/week of vigorous intensity.
p-values were calculated by a X2 test to compare percentages, a Student t test to compare means and a Mann-Whitney test to compare medians.
doi:10.1371/journal.pone.0061549.t001
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arm circumference. Two sets of BP readings were made separated
by 90 minutes. In each set, BP was measured three times at 1–2
minute intervals. In the analyses, BP was calculated as the mean of
at least three out of the last five readings. Hypertension in the
Table 2. Cardiometabolic health status among aware and unaware diabetic individuals.
Aware (n = 661) Unaware (n = 173)
% 95% CI % 95% CI p
Lifestyles factors
Non-smokers 84.6 81.6–87.7 80.5 74.0–87.0 0.234
Body mass index ,25 kg/m2 13.2 10.3–16.2 12.7 6.7–18.7 0.882
Body mass index ,30 kg/m2 53.3 48.8–57.8 50.0 41.1–58.9 0.505
Waist circumference #102/#88 cm (men/women) 29.4 25.4–33.5 31.3 23.0–39.6 0.691
BMI ,25 kg/m2 and waist circumference #102/88 cm 11.4 8.6–14.2 12.7 6.7–18.8 0.688
Physical activity (moderate or intensea) 41.1 36.5–45.7 45.8 37.4–54.2 0.333
Calorie intake from saturated fat ,7% 8.6 6.2–11.1 5.8 2.2–9.4 0.245
Calorie intake from saturated fat ,10% 37.7 33.4–42.0 37.0 28.5–45.5 0.875
Biological factors
HbA1c,7% 70.9 66.8–75.0 84.3 78.1–90.6 0.002
Blood pressure ,130/80 mmHg 21.9 18.1–25.6 29.2 21.1–37.4 0.086
Blood pressure 130–139/80–89 mmHg 28.1 23.9–32.5 24.5 17.1–31.9 0.411
LDL cholesterol ,100 mg/dl 35.6 31.3–39.9 22.1 14.4–29.8 0.006
LDL cholesterol ,115 mg/dl 53.7 49.0–58.4 29.1 21.0–37.1 ,0.001
Urinary albumin: creatinine ratio ,30 mg/g 76.4 72.5–80.3 85.7 79.5–91.8 0.028
Medical advice
Diet to control diabetes 86.7 83.6–89.8 – – –
Adherence to diet to control diabetes 75.1 71.2–78.9 – – –
Reduction of salt consumption in known hypertensives 88.7 85.1–92.3 80.7 70.8–90.6 0.089
Adherence to reduction of salt consumption in known
hypertensives 81.9 77.5–86.4 74.8 63.8–85.8 0.209
Weight reduction (if BMI $25 kg/m2) 74.5 70.2–78.8 62.9 54.1–71.7 0.013
Adherence to weight reduction (if BMI $25 kg/m2) 45.5 40.5–50.4 32.5 23.3–41.6 0.019
Weight loss strategy 38.3 33.6–42.9 27.6 19.4–35.8 0.035
Physical activity at least moderate 85.2 81.6–88.9 70.5 62.4–78.6 ,0.001
Adherence to physical activity at least moderate 64.5 59.8–69.2 43.3 34.8–51.9 ,0.001
Stopping smoking (if daily smokers) 86.4 78.6–94.1 64.5 44.7–84.4 0.021
Smoking cessation strategy (if daily smokers) 19.6 9.2–30.0 8.5 3.1–20.1 0.230
Cardioprotective treatment
Only oral antidiabetics 64.4 60.0–68.7 – – –
Only insulin 10.8 7.9–13.7 – – –
Oral antidiabetics and insulin 9.3 6.8–11.8 – – –
Treatment with ACE inhibitors/ARBs in known
hypertensives 58.8 53.0–64.6 54.8 41.4–68.2 0.580
Treatment with statins (if indicatedb) 37.7 33.2–42.3 28.7 19.9–37.6 0.086
Treatment with aspirin ,500 mg/day (if indicatedc) 15.3 12.1–18.6 6.8 1.7–11.9 0.028
Annual influenza immunization 60.1 55.5–64.8 46.2 37.1–55.3 0.007
Annual influenza immunization in persons .60 years 68.9 63.7–74.0 60.9 50.2–71.6 0.176
Use of health services
Glucose testing 2 or more times per year 53.9 49.2–58.6 38.5 29.7–47.4 0.003
aModerate or vigorous physical activity: $150 minutes/week of moderate intensity or $60 minutes/week of vigorous intensity.
bStatin indications: i) Overt cardiovascular disease (CVD), ii) no CVD and age over 40 with one or more other CVD risk factors, iii) no overt CVD and age under 40 if LDL
cholesterol remains .100 mg/dl, or multiple CVD risk factors.
cLow-dose aspirin indications: history of CVD and age over 40 or additional risk factors (family history of CVD, hypertension, smoking, dyslipidemia, or albuminuria).
p-value was calculated by a X2 test to compare percentages.
doi:10.1371/journal.pone.0061549.t002
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known diabetic population was defined as systolic BP (SBP)
$130 mm Hg, diastolic BP (DBP) $80 mm Hg, or on current
antihypertensive medication.
LDL cholesterol was calculated by the Friedewald formula,
where total cholesterol was measured by the cholesterol-esterase
and cholesterol-oxidase method; HDL cholesterol by the direct
method, by elimination/catalase; and triglycerides by the glycerol
phosphate oxidase method. Creatinine was determined by the
Jaffe´ method (rate-blanked), kinetic reaction. Microalbumin was
determined by PEG enhanced immunoturbidimetry. Glucose was
measured by the glucose oxidase method. The analyzer ADVIA
2400 Chemistry System from Siemens was used for all the above
parameters. HbA1c was measured by chromatography by HPLC
(analyzer ADAMS A1c HA-8160, Arkray). The laboratory tests
were performed centrally at the Center of Biological Diagnosis of
the Hospital Clı´nic in Barcelona, according to standard procedures
and incorporating appropriate quality controls.
Study participants were asked if they had ever been advised by a
physician on lifestyles (diet, salt reduction, physical activity, weight
loss, quitting smoking), with three possible responses: 1) No; 2) Yes,
but I do not follow it; and 3) Yes, and I do follow it. A positive
response to 2 or 3 was considered as receiving advice, and a
positive response to 3 was considered adherence to the advice. A
nurse also recorded each participant’s medication use.
Cardiometabolic Goals
We classified the cardiovascular health status and management
of diabetic patients into five categories: lifestyle, biological factors,
medical advice on lifestyles, cardioprotective treatment, and use of
health care; and goals were taken from well-known guidelines in
effect at the time of the survey [2–4,17]. Among unaware diabetic
subjects, the goals were those recommended for the general
population [3,17].
Lifestyle goals were set as: non-smoker (never or ex-smoker);
normal weight (BMI ,25 kg/m2) and lack of central obesity (WC
Table 3. Achievement of selected cardiometabolic goals among aware vs. unaware diabetic individuals.
95%
Odds ratioa
confidence
interval p
Lifestyles
Non-smokers 1.16 0.73–1.84 0.537
BMI,25 kg/m2 and waist circumference #102/88 cm 0.98 0.58–1.65 0.933
Moderate or intense physical activity 0.88 0.62–1.25 0.479
Calorie intake from saturated fat ,7% 1.49 0.73–3.02 0.271
Calorie intake from saturated fat ,10% 0.97 0.68–1.39 0.884
Biological factors
HbA1c,7% 0.41 0.26–0.65 ,0.001
Blood pressure ,130/80 mmHg 1.31 0.87–1.96 0.196
Blood pressure ,140/90 mmHg 0.95 0.67–1.35 0.771
LDL cholesterol ,100 mg/dl 1.93 1.29–2.90 0.001
LDL cholesterol ,115 mg/dl 2.81 1.94–4.08 ,0.001
Urinary albumin:creatinine ratio ,30 mg/g 0.56 0.35–0.89 0.016
Medical advice
Reduction of salt consumption in known hypertensives 1.88 0.96–3.65 0.064
Adherence to reduction of salt consumption in known hypertensives 1.48 0.82–2.67 0.192
Weight reduction (if BMI $25 kg/m2) 1.81 1.23–2.68 0.003
Adherence to weight reduction (if BMI $25 kg/m2) 1.84 1.25–2.72 0.002
Weight loss strategy 1.77 1.18–2.66 0.006
Physical activity at least moderate 2.42 1.63–3.60 ,0.001
Adherence to physical activity at least moderate 2.36 1.67–3.33 ,0.001
Advice to stop smoking in daily smokers 3.89 0.51–29.8 0.191
Cardioprotective treatment
Treatment with ACE inhibitors/ARBs in known hypertensives 1.22 0.74–2.02 0.443
Treatment with statins if indicated 1.47 1.01–2.15 0.048
Treatment with aspirin ,500 mg/day if indicated 2.50 1.27–4.89 0.008
Annual influenza immunization in persons .60 years 1.44 0.93–2.22 0.100
Use of health services
Glucose testing 2 or more times per year 1.86 1.31–2.63 ,0.001
BMI indicates body mass index; ACE, angiotensin convertin enzime; ARB, angiotensin II receptor blocker.
aOdds ratios among aware diabetic patients vs. those unaware (reference) were adjusted for age, sex, and educational level.
doi:10.1371/journal.pone.0061549.t003
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#102 cm in men and #88 in women); moderate or vigorous
physical activity ($150 minutes/week of moderate intensity or
$60 minutes/week of vigorous intensity); and reduced energy
intake from saturated fat (,7% in aware diabetes and ,10% in
unaware diabetes).
Biological goals were defined as control of: blood glucose
(HbA1c ,7%); systolic and diastolic blood pressure (,130/
80 mmHg in aware diabetes and ,140/90 in unaware diabetes);
LDL cholesterol (,100 mg/dl in aware diabetes and,115 mg/dl
in unaware diabetes); and albumin excretion (urinary albumin:
creatinine ratio ,30 mg/g).
Medical advice goals were receiving advice on and being
adherent to: diet to control blood glucose in aware diabetics and
salt reduction in known hypertensives, weight reduction in subjects
with overweight (BMI $25 kg/m2), at least moderate physical
activity, and smoking cessation.
Cardioprotective treatment goals were being treated with: ACE
inhibitors/ARBs in known hypertensives; statins, if indicated (i)
overt cardiovascular disease (CVD); ii) no CVD and age over 40
with one or more other CVD risk factors; iii) no overt CVD and
age under 40 if LDL cholesterol remains .100 mg/dl, or multiple
CVD risk factors); aspirin ,500 mg/day, if indicated (history of
CVD and age over 40 or additional risk factors, including family
history of CVD, hypertension, smoking, dyslipidemia, or albu-
minuria); and annual influenza immunization (in all aware
diabetics and in unaware diabetics aged 60 years and older).
Lastly, a goal on health care use was set as glucose testing $2
times per year.
Statistical Analysis
From the 12,948 study participants, 871 were excluded due to
lack of valid information on the variables of interest. Thus, the
analyses on the prevalence of diabetes were conducted with 12,077
individuals. To determine the achievement of cardiometabolic
goals according to diabetes awareness status, we limited the
analyses to the 661 aware diabetic patients and 173 unaware
diabetic patients with complete information on variables of
interest.
The analyses took account of the complex sampling design;
thus, individual observations were weighted to reconstruct the
Spanish population, and the variances were corrected to obtain
appropriate 95% confidence intervals (CI) for the main results.
Categorical variables were reported as a percentage and contin-
uous variables as a mean, except for albumin excretion which was
summarized with the median. The X2 test was used to compare
percentages; the Student t test to compare means; and the Mann-
Whitney U test to compare medians. The associations between
each cardiovascular health goal (yes/no) as outcome and
awareness of diabetes (unawareness as reference) as primary
covariate, were summarized with odds ratios (OR) and their 95%
confidence interval (CI), obtained from logistic regression.
Analyses were adjusted for age (continuous), gender, and
educational level (less than high school, high school and
university).
Statistical significance was set at two-sided p,0.05. The
analyses were performed with the survey procedure in STATAH,
version 11.2.
Results
Among the 12,077 participants, 834 (6.9%) had diabetes, of
whom 661 (79.2%) were aware of their condition. Mean age of the
aware diabetic subjects was 64.4 years, 41.7% were women, and
57.7% had less than high school. Mean diabetes duration was 7.7
years and mean HbA1c was 6.5% (Table 1). Unaware and aware
diabetics had similar demographic characteristics in terms of
gender and educational level. However, unaware diabetics were
somewhat younger that aware diabetic individuals (Table 1). As
regards clinical characteristics, both groups had comparable
Figure 1. Percent distribution of the number of cardiometa-
bolic goals (lifestyles and biological factors) met among
diabetic patients. A.- Lifestyle: non-smoker; BMI ,25 kg/m2 and
waist circumference #102/88 cm in men and women, respectively;
moderate or intense physical activity; energy intake from saturated fat
,7%. B.- Biological factors: HbA1c,7%; blood pressure ,130/
80 mmHg; LDL cholesterol ,100 mg/dl; urinary albumin:creatinine
ratio ,30 mg/g C.- Lifestyle and biological factors.
doi:10.1371/journal.pone.0061549.g001
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figures, except for HbA1c and urinary albumin excretion which
were lower in unaware diabetics, and for total and LDL
cholesterol which were lower in aware diabetics (Table 1). Eighty
five percent of aware diabetics were non-smokers (Table 2). Only
13.2% had normal weight (BMI,25 kg/m2) and less than one-
third did not have abdominal obesity. As a result, 11.4% had
neither general nor abdominal obesity. About 8.6% consumed less
than 7% of calories from saturated fat, and 41.1% met the
recommendations for moderate or vigorous physical activity
(Table 2). Glycemic control (HbA1c,7%) was achieved in
70.9% of aware diabetic patients vs. 84.3% of unaware diabetics
(p = 0.002). Only 21.9% of aware diabetics met the BP target
(,130/80 mmHg) compared with 29.2% of unaware diabetics
(p = 0.086). Seven out of ten aware diabetics and eight out of ten
unaware diabetics had a normal urinary albumin excretion
(urinary albumin:creatinine ratio ,30 mg/g) (p = 0.028). In
contrast, 35.6% of aware diabetics reached the LDL cholesterol
goal of,100 mg/dl, while only 29% of unaware diabetics met the
goal for the general population (LDL-cholesterol ,115 mg/dl)
(Table 2).
A large percentage of study participants received medical advice
on lifestyles, although adherence to such advice was low (Table 2).
Only 38.3% of overweight individuals and 19.6% of daily smokers,
who knew their diabetes status, were offered a specific strategy for
weight loss or quitting smoking, respectively. For those unaware of
their condition, these specific strategies were recommended even
less frequently (Table 2).
About 59% of aware diabetic individuals with known hyper-
tension were being treated with ACE inhibitors or ARBs. Only
37.7% of those with statin indication were treated with these
drugs, and as few as 15.3% of those with a clear indication were
being treated with low-dose aspirin. Compared with aware
diabetics, those unaware of their condition were significantly less
likely to be treated with statins or aspirin (Table 2). Around 69% of
persons over age 60 with aware diabetes and 61% with unaware
diabetes had been vaccinated against influenza in the previous
year. Lastly, over one third of unaware diabetics had their blood
glucose levels tested more than twice a year, in contrast with only
half of aware diabetic subjects (p = 0.003) (Table 2).
Table 3 shows the adjusted association between diabetes
awareness and achievement of selected cardiometabolic goals.
Unaware diabetic patients showed a better glycemic control and
renal function, while aware diabetic subjects more frequently had
LDL cholesterol controlled, adhered to advice on weight reduction
and physical activity, and received statin and aspirin treatment.
Figure 1 shows the percent distribution of the number of
cardiometabolic goals met among diabetic patients. About 39% of
both aware and unaware diabetic subjects met two of the four
lifestyle goals (Figure 1, A). As regards biological goals, 90% of the
unaware diabetics reached three or more goals vs. 70% of aware
diabetics (Figure 1, B). None attained all eight lifestyles and
biological factor goals, and only 3 known diabetics achieved seven
of them (Figure 1, C).
Discussion
We examined the achievement of cardiometabolic goals among
diabetics in Spain, and found a situation with large room for
improvement: only three out of five aware diabetics met at least
three of the studied goals.
Of note is the small percentage of aware diabetics who meet the
American Diabetes Association (ADA) [2] recommendations on
intake of saturated fats. This could be explained by a deterioration
in eating habits in Spain during recent decades, which have
progressively departed from the traditional Mediterranean dietary
pattern [18]. In our study, as few as 9% of diabetic patients
consumed ,7% of calories from saturated fats, and only 6%
consumed ,10%. These figures are lower than those found in
other studies (37.7% vs. 48.3% respectively, in the US) [5].
Besides, half of aware diabetic patients had a BMI,30 kg/m2,
which was higher than that reported for the U.S. (37.6%) [5], but
lower than those observed in several Southern European countries
(over 60%) [8,9].
However, achievement of the recommendation on weekly
physical activity was higher in our study than that reported by
Resnick et al. in the U.S. (41.1% vs. 28.2%) [6]; and the majority
of aware diabetic patients were non-smokers, a situation similar to
that in the U.S., where 82.4% of diabetics do not smoke [5].
Glycemic control in Spain is reasonably high, (71% of aware
diabetic patients had HbA1C ,7% vs. 55.2% in the U.S. [5]),
although only one in five had their BP strictly controlled. BP
control among our aware diabetic patients is far lower than in the
U.S., where 40% of subjects had BP,130/80 mmHg [6]. One-
third of people with aware diabetes had LDL-cholesterol
,100 mg/dl, again lower than in U.S. studies [5,19], that could
be explained by less use of statins in Spain. On renal function,
about 77% of persons with known diabetes had a urinary
albumin:creatinine ratio of ,30 mg/g as compared to 65% in
the U.S. studies [5,6], which could be due to the shorter duration
of diabetes in our study (7.7 years vs. 11.4 years, respectively) and
better glucose control. The large proportion of aware diabetic
patients who received advice on lifestyles is similar to that in other
studies in Europe [20], and the U.S. [21,22]. Reported compliance
with the advice was also quite high, except for weight reduction.
However, prescription of a specific method to lose weight or stop
smoking was low, especially in the latter case, which was received
by only one of every six daily smokers. The weight advice data are
consistent with the small percentage of individuals not achieving
normal weight.
We found higher levels of treatment with oral antidiabetics than
in other U.S. and European studies [5,23]. In contrast, treatment
with insulin is lower than in those countries [23]. The percentage
of use of ACE inhibitors or ARBs in aware diabetic persons with
known hypertension in our study was relatively low (58.8%)
considering that, according to recommendations [2,4] all such
persons should receive hypertensive treatment with one drug from
this group. Our data are similar to those of the U.S. [24] and
much lower than the levels of use of ACE inhibitors or ARBs in
hypertensive diabetics in France (82%) [25]. The use of statins in
persons who require this treatment due to their cardiovascular risk
or LDL levels follows the same pattern, far below the ADA
recommendations and lower than found in other studies [19].
Especially low was the treatment with low-dose aspirin as an
antiplatelet drug where recommended among aware diabetic
patients [26,27]. The levels of influenza immunization were
moderate. Around 60% of subjects with aware diabetes were
vaccinated in the previous year. In middle-aged subjects, the levels
were similar to those of the U.S. [28].
In our study, being aware with diabetes was not associated with
an expected better achievement of the goal for HbA1c and urinary
albumin:creatinine ratio. Part of the explanation could be that
those unaware of their diabetes are slightly younger and have had
the disease for less time (data not shown), therefore their renal
function and HbA1c are better preserved. Conversely, being aware
of their diabetes condition was associated with more frequent
control of LDL, medical advice to modify lifestyles, cardioprotec-
tive treatment and use of health services. Interestingly, after
adjusting for age, gender and educational level, no differences
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were found between those with aware and unaware diabetes with
regard to lifestyles, which suggests limited effectiveness of lifestyle
interventions in these patients. However, the relationships between
aware and unaware diabetes patients were cross-sectional, not
permitting drawing causal conclusions, but only suggesting it.
The prevalence of diabetes in our study (6.9%) was lower than
in one recent investigation in Spain [29]. Our study participants
were younger (50% under 45 years vs. 42%), with a lower
proportion of women (50.5% vs. 57.1%) and a lower frequency of
obesity in diabetic patients (48% vs. 55%), which could contribute
to the observed differences in results. In the US, the prevalence of
diabetes (8.6%) [5] is higher than in Spain, which may partly be
due to the higher frequency of obesity among aware diabetic
patients (62.4%) [5].
One strength of this study is that it provides nationally
representative data. However, various study limitations deserve
to be considered. First, we excluded 6.7% of study participants
because of missing data, and performed a complete-case analysis.
Such relatively small levels of exclusion would probably not
substantially affect the overall results. Second, we cannot rule out a
certain selection bias resulting from using phone interviews.
However, it should be noted that over 85% of households in Spain
have a fixed phone line. Moreover, a study in Spain has shown
that phone interviews had good validity and reproducibility with
respect to face-to-face interviews [30]. Third, the sample size was
limited for some analyses such as the specific method recom-
mended to stop smoking, which did not allow to compare persons
with aware and unaware diabetes. Fourth, the information on
medical advice and its adherence was self-reported, therefore it is
subject to recall bias and social desirability bias (i.e., providing a
socially acceptable answer rather than the most accurate answer).
Fifth, we did not distinguish between type 1 and 2 diabetes but it is
likely that, as in many developed countries, the majority of patients
suffered from type 2 diabetes. Lastly, no information was obtained
on pneumococcal immunization.
In conclusion, this study in a European country with universal
healthcare coverage shows that comprehensive achievement of the
cardiometabolic goals and lifestyles recommended by major
international guidelines is not good enough. It suggests that
improvements in both guideline implementation and patients’
adherence are needed [31].
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